Tag: bio pharmaceutical

March 1, 2018

Biocure appoints Lichtenwald CFO, director

Biocure Technology Inc. (formerly Gravis Energy Corp.) (CSE: CURE) (the"Company" or "Biocure") is pleased to announce that effective of today's...
February 20, 2018

BioCure Announces a Contract with Osong Hi-Tech Medical Industry Promotion Foundation

Biocure Technology Inc. (CSE: CURE) (formerly Gravis Energy Corp.) (the “Company” or “Biocure”) announces that on February 19, 2018, has...
January 31, 2018

BioCure Unaware of Any Material Change

Biocure Technology Inc. (formerly Gravis Energy Corp.) (CSE: CURE) (the "Company" or "Biocure) At the request of IIROC, Biocure wishes...
January 29, 2018

Tetra Bio-Pharma Gets Regulatory Approval for Phase 2 Cannabis Oil Trial

Tetra Bio-Pharma announced it obtained Health Canada approval for their phase 2 clinical trial investigating the safety and efficacy of...
August 16, 2017

Tetra Bio-Pharma Joins TSXV, Leaves CSE Behind

Tetra Bio-Pharma announced it has been approved to begin trading on the TSX Venture Exchange and has now applied to...
March 14, 2017

Tetra Bio-Pharma Enters into Binding Term Sheet for Two Products with Panag Pharma

Tetra Bio-Pharma(CSE:TBP) has entered into a binding term sheet with Panag Pharma for the development and commercialization of novel cannabinoid...